Symbenda Post-Marketing Surveillance (PMS)
NCT02434484 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84
Last updated 2021-01-26
Summary
This is a PMS of Symbenda Injection (bendamustine hydrochloride) in Korean Patients. The main objective is to obtain safety information related to Symbenda treatment from clinical practice.
Conditions
- Lymphoma, Non-Hodgkin
- Lymphocytic Leukemia
- Multiple Myeloma
Sponsors & Collaborators
-
Eisai Korea Inc.
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-07-04
- Primary Completion
- 2020-03-20
- Completion
- 2020-03-20
Countries
- South Korea
Study Locations
More Related Trials
-
A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E
NCT06842134 ·Status: COMPLETED ·Phase: PHASE1
-
Continuous NMB in PCAS
NCT02790164 ·Status: COMPLETED ·Phase: PHASE2
-
Study of DA-9501 In Pediatric Subjects In The Intensive Care Unit
NCT02757625 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring
NCT06867289 ·Status: RECRUITING ·Phase: NA
-
Transcricoid Injection vs. Spray as You go Method for Local Anaesthesia During EBUS-TBNA
NCT02981264 ·Status: COMPLETED ·Phase: NA
-
Comparison of Sugammadex and Sugammadex-neostigmine Combination in the Antagonism of Moderate Neuromuscular Block
NCT05228223 ·Status: UNKNOWN ·Phase: NA
-
Pediatric Patients Aged 1 to 6 Years With APDS
NCT05693129 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
NCT01571297 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Dexamethasone on Sugammadex Reversal
NCT02137395 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy, Safety, and Pharmacokinetics of Sugammadex for Reversal of Neuromuscular Blockade (NMB) in Pediatric Participants (MK-8616-089)
NCT03351608 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Pethidine, Ketorolac And Xylocaine Gel As Analgesics For Pain Control In Shockwave Lithotripsy
NCT03032458 ·Status: COMPLETED ·Phase: PHASE4
-
Sugammadex Versus Neostigmine in Pediatric Less Than Two Years Undergoing Cardiac Catheterization
NCT04258007 ·Status: COMPLETED ·Phase: NA
-
Assessment Study of the Effect of NMBA on Bowel Peristalsis
NCT02004015 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE)
NCT02813655 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)
NCT03909165 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Sugammadex in Thoracoscopy Thymectomy for Chinese Adults With Myasthenia Gravis
NCT06436768 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial
NCT02784392 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)
NCT05795465 ·Status: RECRUITING ·Phase: PHASE2
-
Re-Evaluation of Systemic Early Neuromuscular Blockade and Transthoracic Ultrasound Assessment of the Diaphragm
NCT03132896 ·Status: WITHDRAWN
-
Sugammadex Dose Finding Under Two Years Old
NCT06575036 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Venetoclax Combined With Dexamethasone and Etoposide in HLH
NCT05546060 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Determine the Safety, Tolerability and Pharmacokinetics of PMZ-2010 (Centhaquin) in Healthy Volunteers
NCT02408731 ·Status: COMPLETED ·Phase: PHASE1
-
Implementation of an Infusion Management Scheme to Improve Patient Outcome in Tertiary Children's Hospitals
NCT05152446 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Injury
NCT02734966 ·Status: COMPLETED ·Phase: PHASE2
-
Electromyographic Activity of the Respiratory Muscles During Neostigmine or Sugammadex Enhanced Recovery After Neuromuscular Blockade
NCT02403063 ·Status: COMPLETED ·Phase: PHASE4